159 related articles for article (PubMed ID: 33994734)
1. Neuropeptide Substance P Enhances Inflammation-Mediated Tumor Signaling Pathways and Migration and Proliferation of Head and Neck Cancers.
Singh S; Kumaravel S; Dhole S; Roy S; Pavan V; Chakraborty S
Indian J Surg Oncol; 2021 Apr; 12(Suppl 1):93-102. PubMed ID: 33994734
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow mesenchymal stem cells promote head and neck cancer progression through Periostin-mediated phosphoinositide 3-kinase/Akt/mammalian target of rapamycin.
Liu C; Feng X; Wang B; Wang X; Wang C; Yu M; Cao G; Wang H
Cancer Sci; 2018 Mar; 109(3):688-698. PubMed ID: 29284199
[TBL] [Abstract][Full Text] [Related]
3. Substance P and Neurokinin 1 Receptor in Chronic Inflammation and Cancer of the Head and Neck: A Review of the Literature.
Esteban F; Ramos-García P; Muñoz M; González-Moles MÁ
Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010633
[TBL] [Abstract][Full Text] [Related]
4. Potential in vitro therapeutic effects of targeting SP/NK1R system in cervical cancer.
Mozafari M; Ebrahimi S; Darban RA; Hashemy SI
Mol Biol Rep; 2022 Feb; 49(2):1067-1076. PubMed ID: 34766230
[TBL] [Abstract][Full Text] [Related]
5. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
Nizam E; Erin N
Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
[TBL] [Abstract][Full Text] [Related]
6. New insight into the role of substance P/neurokinin-1 receptor system in breast cancer progression and its crosstalk with microRNAs.
Ebrahimi S; Javid H; Alaei A; Hashemy SI
Clin Genet; 2020 Oct; 98(4):322-330. PubMed ID: 32266968
[TBL] [Abstract][Full Text] [Related]
7. Inflammation enhances Y1 receptor signaling, neuropeptide Y-mediated inhibition of hyperalgesia, and substance P release from primary afferent neurons.
Taylor BK; Fu W; Kuphal KE; Stiller CO; Winter MK; Chen W; Corder GF; Urban JH; McCarson KE; Marvizon JC
Neuroscience; 2014 Jan; 256():178-94. PubMed ID: 24184981
[TBL] [Abstract][Full Text] [Related]
8. SP/NK-1R promotes gallbladder cancer cell proliferation and migration.
Deng XT; Tang SM; Wu PY; Li QP; Ge XX; Xu BM; Wang HS; Miao L
J Cell Mol Med; 2019 Dec; 23(12):7961-7973. PubMed ID: 30903649
[TBL] [Abstract][Full Text] [Related]
9. High expression of substance P and its receptor neurokinin-1 receptor in colorectal cancer is associated with tumor progression and prognosis.
Chen XY; Ru GQ; Ma YY; Xie J; Chen WY; Wang HJ; Wang SB; Li L; Jin KT; He XL; Mou XZ
Onco Targets Ther; 2016; 9():3595-602. PubMed ID: 27366097
[TBL] [Abstract][Full Text] [Related]
10. Substance P Receptor Antagonist Suppresses Inflammatory Cytokine Expression in Human Disc Cells.
Kepler CK; Markova DZ; Koerner JD; Mendelis J; Chen CM; Vaccaro AR; Risbud MV; Albert TJ; Anderson DG
Spine (Phila Pa 1976); 2015 Aug; 40(16):1261-9. PubMed ID: 25929203
[TBL] [Abstract][Full Text] [Related]
11. SP promotes cell proliferation in esophageal squamous cell carcinoma through the NK1R/Hes1 axis.
Wang F; Liu S; Liu J; Feng F; Guo Y; Zhang W; Zheng G; Wang Q; Cai L; Guo M; Lian X; Xu G; Zhang H
Biochem Biophys Res Commun; 2019 Jul; 514(4):1210-1216. PubMed ID: 31109645
[TBL] [Abstract][Full Text] [Related]
12. miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer.
Yu CC; Tsai LL; Wang ML; Yu CH; Lo WL; Chang YC; Chiou GY; Chou MY; Chiou SH
Cancer Res; 2013 Jun; 73(11):3425-40. PubMed ID: 23548270
[TBL] [Abstract][Full Text] [Related]
13. Substance P Promotes the Progression of Endometrial Adenocarcinoma.
Ma J; Yuan S; Cheng J; Kang S; Zhao W; Zhang J
Int J Gynecol Cancer; 2016 Jun; 26(5):845-50. PubMed ID: 27051050
[TBL] [Abstract][Full Text] [Related]
14. Neurotransmitter substance P mediates pancreatic cancer perineural invasion via NK-1R in cancer cells.
Li X; Ma G; Ma Q; Li W; Liu J; Han L; Duan W; Xu Q; Liu H; Wang Z; Sun Q; Wang F; Wu E
Mol Cancer Res; 2013 Mar; 11(3):294-302. PubMed ID: 23345604
[TBL] [Abstract][Full Text] [Related]
15. Keratinocytes express cytokines and nerve growth factor in response to neuropeptide activation of the ERK1/2 and JNK MAPK transcription pathways.
Shi X; Wang L; Clark JD; Kingery WS
Regul Pept; 2013 Sep; 186():92-103. PubMed ID: 23958840
[TBL] [Abstract][Full Text] [Related]
16. Involvement of DNMT 3B promotes epithelial-mesenchymal transition and gene expression profile of invasive head and neck squamous cell carcinomas cell lines.
Chen LH; Hsu WL; Tseng YJ; Liu DW; Weng CF
BMC Cancer; 2016 Jul; 16():431. PubMed ID: 27391030
[TBL] [Abstract][Full Text] [Related]
17. The neuropeptide substance P is a critical mediator of burn-induced acute lung injury.
Sio SW; Puthia MK; Lu J; Moochhala S; Bhatia M
J Immunol; 2008 Jun; 180(12):8333-41. PubMed ID: 18523300
[TBL] [Abstract][Full Text] [Related]
18. Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer.
Chen CH; Chang AY; Li SH; Tsai HT; Shiu LY; Su LJ; Wang WL; Chiu TJ; Luo SD; Huang TL; Chien CY
Mol Cancer; 2015 Apr; 14():83. PubMed ID: 25889801
[TBL] [Abstract][Full Text] [Related]
19. Advances in Head and Neck Cancer Pain.
Ye Y; Jensen DD; Viet CT; Pan HL; Campana WM; Amit M; Boada MD
J Dent Res; 2022 Aug; 101(9):1025-1033. PubMed ID: 35416080
[TBL] [Abstract][Full Text] [Related]
20. SP/NK1R system regulates carcinogenesis in prostate cancer: Shedding light on the antitumoral function of aprepitant.
Ebrahimi S; Mirzavi F; Aghaee-Bakhtiari SH; Hashemy SI
Biochim Biophys Acta Mol Cell Res; 2022 May; 1869(5):119221. PubMed ID: 35134443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
